Mounjaro (Tirzepatide) is a weekly injectable GLP-1 and GIP receptor agonist medication FDA approved for Chronic Weight Management (2023) and for Type 2 Diabetes (2022).
Weight Loss Book (pdf)
Download912-295-5560
119 Chimmey Road, Rincon, Georgia 31326, United States
Open today | 08:00 am – 07:00 pm |
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.